Parry Sharon P, Coenen Pieter, Shrestha Nipun, O'Sullivan Peter B, Maher Christopher G, Straker Leon M
Curtin University, School of Physiotherapy and Exercise Science, Kent Street, Bentley, Perth, West Australia, Australia, 6102.
VU University Medical Center, Department of Public and Occupational Health, EMGO Institute for Health and Care Research, van der Boechorststraat 7, Amsterdam, Netherlands, 1081BT.
Cochrane Database Syst Rev. 2019 Nov 17;2019(11):CD012487. doi: 10.1002/14651858.CD012487.pub2.
The prevalence of musculoskeletal symptoms among sedentary workers is high. Interventions that promote occupational standing or walking have been found to reduce occupational sedentary time, but it is unclear whether these interventions ameliorate musculoskeletal symptoms in sedentary workers.
To investigate the effectiveness of workplace interventions to increase standing or walking for decreasing musculoskeletal symptoms in sedentary workers.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, OSH UPDATE, PEDro, ClinicalTrials.gov, and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal up to January 2019. We also screened reference lists of primary studies and contacted experts to identify additional studies.
We included randomised controlled trials (RCTs), cluster-randomised controlled trials (cluster-RCTs), quasi RCTs, and controlled before-and-after (CBA) studies of interventions to reduce or break up workplace sitting by encouraging standing or walking in the workplace among workers with musculoskeletal symptoms. The primary outcome was self-reported intensity or presence of musculoskeletal symptoms by body region and the impact of musculoskeletal symptoms such as pain-related disability. We considered work performance and productivity, sickness absenteeism, and adverse events such as venous disorders or perinatal complications as secondary outcomes.
Two review authors independently screened titles, abstracts, and full-text articles for study eligibility. These review authors independently extracted data and assessed risk of bias. We contacted study authors to request additional data when required. We used GRADE considerations to assess the quality of evidence provided by studies that contributed to the meta-analyses.
We found ten studies including three RCTs, five cluster RCTs, and two CBA studies with a total of 955 participants, all from high-income countries. Interventions targeted changes to the physical work environment such as provision of sit-stand or treadmill workstations (four studies), an activity tracker (two studies) for use in individual approaches, and multi-component interventions (five studies). We did not find any studies that specifically targeted only the organisational level components. Two studies assessed pain-related disability. Physical work environment There was no significant difference in the intensity of low back symptoms (standardised mean difference (SMD) -0.35, 95% confidence interval (CI) -0.80 to 0.10; 2 RCTs; low-quality evidence) nor in the intensity of upper back symptoms (SMD -0.48, 95% CI -.096 to 0.00; 2 RCTs; low-quality evidence) in the short term (less than six months) for interventions using sit-stand workstations compared to no intervention. No studies examined discomfort outcomes at medium (six to less than 12 months) or long term (12 months and more). No significant reduction in pain-related disability was noted when a sit-stand workstation was used compared to when no intervention was provided in the medium term (mean difference (MD) -0.4, 95% CI -2.70 to 1.90; 1 RCT; low-quality evidence). Individual approach There was no significant difference in the intensity or presence of low back symptoms (SMD -0.05, 95% CI -0.87 to 0.77; 2 RCTs; low-quality evidence), upper back symptoms (SMD -0.04, 95% CI -0.92 to 0.84; 2 RCTs; low-quality evidence), neck symptoms (SMD -0.05, 95% CI -0.68 to 0.78; 2 RCTs; low-quality evidence), shoulder symptoms (SMD -0.14, 95% CI -0.63 to 0.90; 2 RCTs; low-quality evidence), or elbow/wrist and hand symptoms (SMD -0.30, 95% CI -0.63 to 0.90; 2 RCTs; low-quality evidence) for interventions involving an activity tracker compared to an alternative intervention or no intervention in the short term. No studies provided outcomes at medium term, and only one study examined outcomes at long term. Organisational level No studies evaluated the effects of interventions solely targeted at the organisational level. Multi-component approach There was no significant difference in the proportion of participants reporting low back symptoms (risk ratio (RR) 0.93, 95% CI 0.69 to 1.27; 3 RCTs; low-quality evidence), neck symptoms (RR 1.00, 95% CI 0.76 to 1.32; 3 RCTs; low-quality evidence), shoulder symptoms (RR 0.83, 95% CI 0.12 to 5.80; 2 RCTs; very low-quality evidence), and upper back symptoms (RR 0.88, 95% CI 0.76 to 1.32; 3 RCTs; low-quality evidence) for interventions using a multi-component approach compared to no intervention in the short term. Only one RCT examined outcomes at medium term and found no significant difference in low back symptoms (MD -0.40, 95% CI -1.95 to 1.15; 1 RCT; low-quality evidence), upper back symptoms (MD -0.70, 95% CI -2.12 to 0.72; low-quality evidence), and leg symptoms (MD -0.80, 95% CI -2.49 to 0.89; low-quality evidence). There was no significant difference in the proportion of participants reporting low back symptoms (RR 0.89, 95% CI 0.57 to 1.40; 2 RCTs; low-quality evidence), neck symptoms (RR 0.67, 95% CI 0.41 to 1.08; two RCTs; low-quality evidence), and upper back symptoms (RR 0.52, 95% CI 0.08 to 3.29; 2 RCTs; low-quality evidence) for interventions using a multi-component approach compared to no intervention in the long term. There was a statistically significant reduction in pain-related disability following a multi-component intervention compared to no intervention in the medium term (MD -8.80, 95% CI -17.46 to -0.14; 1 RCT; low-quality evidence).
AUTHORS' CONCLUSIONS: Currently available limited evidence does not show that interventions to increase standing or walking in the workplace reduced musculoskeletal symptoms among sedentary workers at short-, medium-, or long-term follow up. The quality of evidence is low or very low, largely due to study design and small sample sizes. Although the results of this review are not statistically significant, some interventions targeting the physical work environment are suggestive of an intervention effect. Therefore, in the future, larger cluster-RCTs recruiting participants with baseline musculoskeletal symptoms and long-term outcomes are needed to determine whether interventions to increase standing or walking can reduce musculoskeletal symptoms among sedentary workers and can be sustained over time.
久坐办公人员中肌肉骨骼症状的患病率很高。已发现促进职业站立或行走的干预措施可减少职业久坐时间,但尚不清楚这些干预措施是否能改善久坐办公人员的肌肉骨骼症状。
研究工作场所干预措施增加站立或行走对减轻久坐办公人员肌肉骨骼症状的有效性。
我们检索了截至2019年1月的Cochrane对照试验中心注册库(CENTRAL)、MEDLINE、Embase、职业安全与健康更新数据库(OSH UPDATE)、PEDro、ClinicalTrials.gov以及世界卫生组织(WHO)国际临床试验注册平台(ICTRP)搜索门户。我们还筛选了主要研究的参考文献列表并联系专家以识别其他研究。
我们纳入了随机对照试验(RCT)、整群随机对照试验(整群RCT)、准随机对照试验以及对照前后(CBA)研究,这些研究旨在通过鼓励有肌肉骨骼症状的工作人员在工作场所站立或行走来减少或打破工作场所的久坐状态。主要结局是按身体部位自我报告的肌肉骨骼症状强度或存在情况以及肌肉骨骼症状(如与疼痛相关的残疾)的影响。我们将工作绩效和生产力、病假缺勤以及静脉疾病或围产期并发症等不良事件视为次要结局。
两位综述作者独立筛选标题、摘要和全文文章以确定研究的纳入资格。这些综述作者独立提取数据并评估偏倚风险。必要时,我们联系研究作者以获取额外数据。我们使用GRADE考量来评估纳入荟萃分析的研究提供的证据质量。
我们发现了10项研究,包括3项RCT、5项整群RCT和2项CBA研究,共有955名参与者,均来自高收入国家。干预措施针对物理工作环境的改变,如提供坐站两用或跑步机工作站(4项研究)、用于个体方法的活动追踪器(2项研究)以及多成分干预措施(5项研究)。我们未发现任何仅针对组织层面因素的研究。两项研究评估了与疼痛相关的残疾情况。物理工作环境:与无干预相比,使用坐站两用工作站的干预措施在短期内(少于6个月),下背部症状强度(标准化均数差(SMD)-0.35,95%置信区间(CI)-0.80至0.10;2项RCT;低质量证据)或上背部症状强度(SMD -0.48,95%CI -0.96至0.00;2项RCT;低质量证据)均无显著差异。没有研究在中期(6至少于12个月)或长期(12个月及以上)检查不适结局。与未提供干预相比,在中期使用坐站两用工作站时,未观察到与疼痛相关的残疾有显著降低(均数差(MD)-0.4,95%CI -2.70至1.90;1项RCT;低质量证据)。个体方法:与替代干预或无干预相比,涉及活动追踪器的干预措施在短期内,下背部症状强度或存在情况(SMD -0.05,95%CI -0.87至0.77;2项RCT;低质量证据)、上背部症状(SMD -0.04,95%CI -